SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹13 Cr | ₹10 Cr | ₹10 Cr | ₹8.57 Cr | ₹7.09 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹13 Cr |
| Mar2025 | ₹10 Cr |
| Mar2024 | ₹10 Cr |
| Mar2023 | ₹8.57 Cr |
| Mar2022 | ₹7.09 Cr |
How is Deferred Tax Assets / Liabilities of SAKAR HEALTHCARE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹13 Cr | 24.30 | |
| Mar2025 | ₹10 Cr | 3.18 | |
| Mar2024 | ₹10 Cr | 16.94 | |
| Mar2023 | ₹8.57 Cr | 20.87 | |
| Mar2022 | ₹7.09 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,065.3 Cr | 5.2% | -16.5% | 153.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | -0.1% | -6.5% | 3.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | -0.2% | -5.5% | 35.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 0.4% | -8.2% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 1.7% | -2% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 4.9% | 7.7% | -2.5% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 5.2% |
-16.5% |
153.1% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses